Myriad Genetics (MYGN) Tmuɣli n wazal
Myriad Genetics
Ṛṛbem n lḥedd$4.16Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel0.00%
Asnulfu n AI: MYGN
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Myriad Genetics, Inc. develops and sells molecular diagnostic products to provide physicians with information that helps them care for their patients, prevent infection, and detect disease at an early stage.
